GeneReach Biotechnology Corp.

TPEX:4171 Stock Report

Market Cap: NT$1.9b

GeneReach Biotechnology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for GeneReach Biotechnology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth20.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Does GeneReach Biotechnology (GTSM:4171) Have A Healthy Balance Sheet?

Apr 18
Does GeneReach Biotechnology (GTSM:4171) Have A Healthy Balance Sheet?

Will Weakness in GeneReach Biotechnology Corp.'s (GTSM:4171) Stock Prove Temporary Given Strong Fundamentals?

Feb 28
Will Weakness in GeneReach Biotechnology Corp.'s (GTSM:4171) Stock Prove Temporary Given Strong Fundamentals?

We Like GeneReach Biotechnology's (GTSM:4171) Returns And Here's How They're Trending

Jan 31
We Like GeneReach Biotechnology's (GTSM:4171) Returns And Here's How They're Trending

The GeneReach Biotechnology (GTSM:4171) Share Price Is Up 596% And Shareholders Are Delighted

Dec 27
The GeneReach Biotechnology (GTSM:4171) Share Price Is Up 596% And Shareholders Are Delighted

GeneReach Biotechnology Corp.'s (GTSM:4171) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Nov 28
GeneReach Biotechnology Corp.'s (GTSM:4171) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as GeneReach Biotechnology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4171 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2023256-161-3312N/A
6/30/2023314-99106158N/A
3/31/202358384136193N/A
12/31/2022750221307358N/A
9/30/2022886338521551N/A
6/30/20221,063411468487N/A
3/31/20221,015383403419N/A
12/31/20211,012377328349N/A
9/30/20211,075404116152N/A
6/30/2021979362119169N/A
3/31/2021961337174239N/A
12/31/2020857257105170N/A
9/30/2020695181120173N/A
6/30/2020589131343N/A
3/31/202040970-35-15N/A
12/31/201936677-25-11N/A
9/30/201929964-42-34N/A
6/30/201926250-23-18N/A
3/31/201923243810N/A
12/31/20181872936N/A
9/30/2018170-3710N/A
6/30/2018163-131113N/A
3/31/2018159-26-5-3N/A
12/31/2017155-48-8-7N/A
9/30/2017149-39-6-4N/A
6/30/2017151-43N/A-9N/A
3/31/2017148-48N/A-9N/A
12/31/2016150-39N/A5N/A
9/30/2016154-28N/A12N/A
6/30/2016155-12N/A9N/A
3/31/2016155-18N/A7N/A
12/31/2015149-25N/A-4N/A
9/30/2015139-22N/A-20N/A
6/30/2015148-31N/A-23N/A
3/31/2015139-31N/A-18N/A
12/31/2014134-30N/A-13N/A
9/30/2014129-40N/A-3N/A
6/30/2014106-49N/A3N/A
3/31/2014106-55N/A-10N/A
12/31/201396-58N/A-14N/A
9/30/201399-47N/A-39N/A
6/30/2013101-41N/A-43N/A
3/31/201395-35N/A-47N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4171's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if 4171's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4171's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4171's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4171's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 4171's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.